Page results
-
BBC News at the NHNN
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
This page tells you about having a Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
-
Find & Treat's new prototype Eco-Tricycle will visit parks, hostels, soup kitchens, be able to arrive under bridges or other street outreach locations to screen homeless patients for infectious diseases and more.
-
With all eyes on Paris for this summer’s Olympic Games, we look at how UCLH’s Institute of Sport, Health and Exercise (ISEH) has supported one of Britian’s Olympic hopefuls, and the care it provides for all kinds of sportspeople, from professionals to weekend warriors.
-
UCLH Private Healthcare: world-class consultants, advanced treatments, and personalised care in central London.
-
This leaflet explains what strong opioid patches are, and how they are used for pain relief at UCLH.
-
This information is for patients who have attended the emergency department with an undisplaced or minimally displaced fracture (broken bone) at the base of your 5th metatarsal.
File results
-
FOI/2023/0034 - Trusts video consultation solutions
-
FOI/2023/0025 - Surgical operating tables used in Trust
-
FOI/2023/0037 - Assault attendances to Emergency Department
-
FOI/2023/0038 - Cases where breast milk of a new mother was given to a child who is not her own
-
FOI/2023/0063 - Women who have given birth at the Trust aged 50 or above
-
FOI/2023/0065 - A&E deaths from 2010 to 2022
-
FOI/2023/0064 - Children's operations cancelled/ delayed for non-clinical reasons from 2018 to 2022
-
FOI/2022/0794 - Communication personnel and communication spend
-
FOI/2023/0058 - Skin cancer pathway management
-
FOI/2023/0054 - Local formulary used at the Trust